Experiments in ER+ breast cancer cell lines demonstrate that activation of the IGF‐1R signaling pathway is associated with PI3K/MAPK pathway signaling, p‐ERα(Ser167) phosphorylation and cell proliferation in the presence of tamoxifen. The gene discussed is ESR1; the disease is breast cancer.